Experiment 1310363

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

PENT-2-ENE-1-YL,1-HYDROXY-4-OXO: CYCLO: (5R)-5-(4-{(1S-5R)-1-HYDROXY-5-[(2S-TRANS-3)-2-HYDROXY-PENT-3-EN-1-YL}-BUTYL}: DIHYDRO-FURAN-2(3H)-ONE:PENT-2-ENE-1-YL,CYCLO: (4-{(1S-5R)-1-HYDROXY-4-OXO-5-[(TRANS-3)-2-OXO-PENT-3-EN-1-YL]--BUTYL}:(5R)-5- DIHYDRO-FURAN-2(3H)-ONE:PENT-2-ENE-1-YL,1-HYDROXY-4-OXO: CYCLO: (5R)-5- (4-{1S-TRANS-5)-5-{[(2S-3S)-3-ETHYL-OXIRAN-2-YL]-METHYLIDENE}-BUTYL}: DIHYDRO-FURAN-2(3H)-ONE:PENT-2-ENE-1-YL,1-HYDROXY-4-OXO: CYCLO: (5R)-5-(4-{(1S-5R)-1-HYDROXY-5-[(2R-TRANS-3)-2-HYDROXY-PENT-3-EN-1-YL]-BUTYL}: DIHYDRO-FURAN-2(3H)-ONE:

Alerts

SEE ARTICLE FOR OTHER TEST RESULTS.

Details

PropertyValue
Pharmacology
ANTIBACTERIAL ACTIVITY
OrganismTectona philippinensis (VERBENACEAE)
CitationRAGASA,CY: TEPORA,MM: ESPINELLI,DH: MANDIA,EH: RIDEOUT,JA:. (2008). CHROMOMORIC ACID DERIVATIVES FROM TECTONA PHILIPPINENSIS. 71(4)
Amount utilized
Compound isolated
Dose amount30 MCG
Number5
Qualitative resultEQUIVOCAL
AnimalAGAR PLATE
Per unitDISC
Dose expressionCONC USED